Format
Sort by

Send to

Choose Destination

Search results

Items: 16

1.

Developability of Biotherapeutics: Computational Approaches. Edited by Sandeep Kumar and Satish K. Singh.

Deane CM, Vásquez M.

MAbs. 2016 Nov 7:0. [Epub ahead of print] No abstract available.

PMID:
27819529
2.

Broad epitope coverage of a human in vitro antibody library.

Sivasubramanian A, Estep P, Lynaugh H, Yu Y, Miles A, Eckman J, Schutz K, Piffath C, Boland N, Niles RH, Durand S, Boland T, Vásquez M, Xu Y, Abdiche Y.

MAbs. 2016 Oct 17:1-14. [Epub ahead of print]

PMID:
27748644
3.

Target-independent variable region mediated effects on antibody clearance can be FcRn independent.

Kelly RL, Yu Y, Sun T, Caffry I, Lynaugh H, Brown M, Jain T, Xu Y, Wittrup KD.

MAbs. 2016 Oct;8(7):1269-1275.

PMID:
27610650
4.

Context matters: The importance of dimerization-induced conformation of the LukGH leukocidin of Staphylococcus aureus for the generation of neutralizing antibodies.

Badarau A, Rouha H, Malafa S, Battles MB, Walker L, Nielson N, Dolezilkova I, Teubenbacher A, Banerjee S, Maierhofer B, Weber S, Stulik L, Logan DT, Welin M, Mirkina I, Pleban C, Zauner G, Gross K, Jägerhofer M, Magyarics Z, Nagy E.

MAbs. 2016 Oct;8(7):1347-1360.

5.

Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak.

Bornholdt ZA, Turner HL, Murin CD, Li W, Sok D, Souders CA, Piper AE, Goff A, Shamblin JD, Wollen SE, Sprague TR, Fusco ML, Pommert KB, Cavacini LA, Smith HL, Klempner M, Reimann KA, Krauland E, Gerngross TU, Wittrup KD, Saphire EO, Burton DR, Glass PJ, Ward AB, Walker LM.

Science. 2016 Mar 4;351(6277):1078-83. doi: 10.1126/science.aad5788.

6.

The INNs and outs of antibody nonproprietary names.

Jones TD, Carter PJ, Plückthun A, Vásquez M, Holgate RG, Hötzel I, Popplewell AG, Parren PW, Enzelberger M, Rademaker HJ, Clark MR, Lowe DC, Dahiyat BI, Smith V, Lambert JM, Wu H, Reilly M, Haurum JS, Dübel S, Huston JS, Schirrmann T, Janssen RA, Steegmaier M, Gross JA, Bradbury AR, Burton DR, Dimitrov DS, Chester KA, Glennie MJ, Davies J, Walker A, Martin S, McCafferty J, Baker MP.

MAbs. 2016;8(1):1-9. doi: 10.1080/19420862.2015.1114320.

7.

Understanding ForteBio's Sensors for High-Throughput Kinetic and Epitope Screening for Purified Antibodies and Yeast Culture Supernatant.

Yu Y, Mitchell S, Lynaugh H, Brown M, Nobrega RP, Zhi X, Sun T, Caffry I, Cao Y, Yang R, Burnina I, Xu Y, Estep P.

J Biomol Screen. 2016 Jan;21(1):88-95. doi: 10.1177/1087057115609564.

8.

Industrial production of clotting factors: Challenges of expression, and choice of host cells.

Kumar SR.

Biotechnol J. 2015 Jul;10(7):995-1004. doi: 10.1002/biot.201400666. Review.

PMID:
26099845
9.

An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies.

Estep P, Caffry I, Yu Y, Sun T, Cao Y, Lynaugh H, Jain T, Vásquez M, Tessier PM, Xu Y.

MAbs. 2015;7(3):553-61. doi: 10.1080/19420862.2015.1016694.

10.

Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA.

Almagro JC, Gilliland GL, Breden F, Scott JK, Sok D, Pauthner M, Reichert JM, Helguera G, Andrabi R, Mabry R, Bléry M, Voss JE, Laurén J, Abuqayyas L, Barghorn S, Ben-Jacob E, Crowe JE Jr, Huston JS, Johnston SA, Krauland E, Lund-Johansen F, Marasco WA, Parren PW, Xu KY.

MAbs. 2014 May-Jun;6(3):577-618. doi: 10.4161/mabs.28421.

11.

High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy.

Liu Y, Caffry I, Wu J, Geng SB, Jain T, Sun T, Reid F, Cao Y, Estep P, Yu Y, Vásquez M, Tessier PM, Xu Y.

MAbs. 2014 Mar-Apr;6(2):483-92. doi: 10.4161/mabs.27431.

12.

Addressing polyspecificity of antibodies selected from an in vitro yeast presentation system: a FACS-based, high-throughput selection and analytical tool.

Xu Y, Roach W, Sun T, Jain T, Prinz B, Yu TY, Torrey J, Thomas J, Bobrowicz P, Vásquez M, Wittrup KD, Krauland E.

Protein Eng Des Sel. 2013 Oct;26(10):663-70. doi: 10.1093/protein/gzt047.

13.

High throughput detection of antibody self-interaction by bio-layer interferometry.

Sun T, Reid F, Liu Y, Cao Y, Estep P, Nauman C, Xu Y.

MAbs. 2013 Nov-Dec;5(6):838-41. doi: 10.4161/mabs.26186.

14.

High throughput solution-based measurement of antibody-antigen affinity and epitope binning.

Estep P, Reid F, Nauman C, Liu Y, Sun T, Sun J, Xu Y.

MAbs. 2013 Mar-Apr;5(2):270-8. doi: 10.4161/mabs.23049.

15.

8(th) Annual European Antibody Congress 2012: November 27-28, 2012, Geneva, Switzerland.

Beck A, Carter PJ, Gerber HP, Lugovskoy AA, Wurch T, Junutula JR, Kontermann RE, Mabry R.

MAbs. 2013 May-Jun;5(3):339-57. doi: 10.4161/mabs.24105.

16.

High-throughput screening and selection of yeast cell lines expressing monoclonal antibodies.

Barnard GC, Kull AR, Sharkey NS, Shaikh SS, Rittenhour AM, Burnina I, Jiang Y, Li F, Lynaugh H, Mitchell T, Nett JH, Nylen A, Potgieter TI, Prinz B, Rios SE, Zha D, Sethuraman N, Stadheim TA, Bobrowicz P.

J Ind Microbiol Biotechnol. 2010 Sep;37(9):961-71. doi: 10.1007/s10295-010-0746-1.

PMID:
20711797
Items per page

Supplemental Content

Loading ...
Support Center